Literature DB >> 31772998

Neutron Radiation Therapy for Treatment of Refractory Merkel Cell Carcinoma.

Meghan W Macomber1, Erica S Tarabadkar2, Nina A Mayr1, George E Laramore1, Shailender Bhatia3,4, Yolanda D Tseng1, Jay Liao1, Tom Arbuckle1, Paul Nghiem2, Upendra Parvathaneni1.   

Abstract

We describe the first reported use of neutron radiation therapy for successful palliation of treatment refractory Merkel cell carcinoma. The patient was a 78-year-old man with Merkel cell carcinoma involving the scalp and bilateral cervical lymph nodes. The extensive coalescing scalp lesions were locally destructive, painful, and highly detrimental to his overall quality of life, and he had previously progressed through 3 courses of conventional x-ray-based radiation therapy and multiple immunotherapy regimens. We treated him with neutron radiation therapy, and he experienced a complete and durable local response with minimal toxicity. High linear energy transfer particle therapy approaches deserve consideration as a treatment option in cancers that are refractory to standard radiation therapy. © Copyright 2017 International Journal of Particle Therapy.

Entities:  

Keywords:  Merkel cell carcinoma; high LET radiation; neutron radiation therapy; palliation; particle therapy

Year:  2017        PMID: 31772998      PMCID: PMC6871561          DOI: 10.14338/IJPT-17-00003.1

Source DB:  PubMed          Journal:  Int J Part Ther        ISSN: 2331-5180


  20 in total

Review 1.  Current concepts for the combined treatment modality of ionizing radiation with anticancer agents.

Authors:  Christoph Oehler; Daniel J Dickinson; Angela Broggini-Tenzer; Barbara Hofstetter; Andreas Hollenstein; Oliver Riesterer; Van Vuong; Martin Pruschy
Journal:  Curr Pharm Des       Date:  2007       Impact factor: 3.116

2.  Merkel cell carcinoma adjuvant therapy: current data support radiation but not chemotherapy.

Authors:  Kelly M Garneski; Paul Nghiem
Journal:  J Am Acad Dermatol       Date:  2007-05-07       Impact factor: 11.527

3.  Second report on results of a randomised clinical trial of fast neutrons compared with chi or gamma rays in treatment of advanced tumours of head and neck.

Authors:  M Catterall; D K Bewley; I Sutherland
Journal:  Br Med J       Date:  1977-06-25

Review 4.  The use of neutron beam therapy in the management of locally advanced nonresectable radioresistant tumors.

Authors:  F R Hendrickson
Journal:  CA Cancer J Clin       Date:  1988 Nov-Dec       Impact factor: 508.702

5.  Observations on pulmonary metastases in patients after single doses and multiple fractions of fast neutrons and cobalt-60 gamma rays.

Authors:  J J Battermann; K Breur; G A Hart; H A van Peperzeel
Journal:  Eur J Cancer       Date:  1981-05       Impact factor: 9.162

6.  Avelumab in patients with chemotherapy-refractory metastatic Merkel cell carcinoma: a multicentre, single-group, open-label, phase 2 trial.

Authors:  Howard L Kaufman; Jeffery Russell; Omid Hamid; Shailender Bhatia; Patrick Terheyden; Sandra P D'Angelo; Kent C Shih; Céleste Lebbé; Gerald P Linette; Michele Milella; Isaac Brownell; Karl D Lewis; Jochen H Lorch; Kevin Chin; Lisa Mahnke; Anja von Heydebreck; Jean-Marie Cuillerot; Paul Nghiem
Journal:  Lancet Oncol       Date:  2016-09-01       Impact factor: 41.316

7.  The role of radiotherapy alone in patients with merkel cell carcinoma: reporting the Australian experience of 43 patients.

Authors:  Michael Veness; Matthew Foote; Val Gebski; Michael Poulsen
Journal:  Int J Radiat Oncol Biol Phys       Date:  2009-11-24       Impact factor: 7.038

8.  Neutron radiotherapy for the treatment of locally advanced major salivary gland tumors.

Authors:  J G Douglas; S Lee; G E Laramore; M Austin-Seymour; W Koh; T W Griffin
Journal:  Head Neck       Date:  1999-05       Impact factor: 3.147

9.  The importance of postoperative radiation therapy in the treatment of Merkel cell carcinoma.

Authors:  J A Meeuwissen; R G Bourne; J H Kearsley
Journal:  Int J Radiat Oncol Biol Phys       Date:  1995-01-15       Impact factor: 7.038

10.  Response rates and durability of chemotherapy among 62 patients with metastatic Merkel cell carcinoma.

Authors:  Jayasri G Iyer; Astrid Blom; Ryan Doumani; Christopher Lewis; Erica S Tarabadkar; Austin Anderson; Christine Ma; Amy Bestick; Upendra Parvathaneni; Shailender Bhatia; Paul Nghiem
Journal:  Cancer Med       Date:  2016-07-19       Impact factor: 4.452

View more
  2 in total

1.  Comparisons of 3-Dimensional Conformal and Intensity-Modulated Neutron Therapy for Head and Neck Cancers.

Authors:  Natalie Viscariello; Matthew D Greer; Upendra Parvathaneni; Jay J Liao; George E Laramore; Robert D Stewart
Journal:  Int J Part Ther       Date:  2021-09-14

Review 2.  Fast and Furious: Fast Neutron Therapy in Cancer Treatment.

Authors:  Konstantin Gordon; Igor Gulidov; Timur Fatkhudinov; Sergey Koryakin; Andrey Kaprin
Journal:  Int J Part Ther       Date:  2022-08-05
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.